title: Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation.
abstract: Dysregulated metal ions are hypothesized to play a role in the aggregation of the amyloid-β (Aβ) peptide, leading to Alzheimer's disease (AD) pathology. In addition to direct effects on Aβ aggregation, both Cu and Fe can catalyze the generation of reactive oxygen species (ROS), possibly contributing to significant neuronal toxicity. Therefore, disruption of metal-Aβ interactions has become a viable strategy for AD therapeutic development. Herein, we report a new series of dual-function triazole-pyridine ligands [4-(2-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)ethyl)morpholine (L1), 3-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)propan-1-ol (L2), 2-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)acetic acid (L3), and 5-(4-(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)pentan-1-amine (L4)] that interact with the Aβ peptide and modulate its aggregation in vitro. Metal chelation and Aβ interaction properties of these molecules were studied by UV-vis, NMR spectroscopy and X-ray crystallography. In addition, turbidity and transmission electron microscopy (TEM) were employed to determine the anti-aggregation properties of L1-L4. All compounds demonstrated an ability to limit metal-induced Aβ aggregation. Overall, our studies suggest the utility of the triazole-pyridine framework in the development of chemical reagents toward inhibitors for metal-triggered Aβ aggregation.
authors: Department of Chemistry, Simon Fraser University, Burnaby, BC V5A1S6, Canada.
authors: Michael R
authors: MR
authors: Jones
authors: Erin L
authors: EL
authors: Service
authors: John R
authors: JR
authors: Thompson
authors: Michael C P
authors: MC
authors: Wang
authors: Isaac J
authors: IJ
authors: Kimsey
authors: Alaina S
authors: AS
authors: DeToma
authors: Ayyalusamy
authors: A
authors: Ramamoorthy
authors: Mi Hee
authors: MH
authors: Lim
authors: Tim
authors: T
authors: Storr
mesh_terms: D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000648:ultrastructure; D018360:Crystallography, X-Ray; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D008670:Metals / Q000737:chemistry*; D008958:Models, Molecular; D020836:Protein Structure, Quaternary; D011725:Pyridines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D012996:Solutions; D013056:Spectrophotometry, Ultraviolet; D014230:Triazoles / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D008024:Ligands; D008670:Metals; D011725:Pyridines; D012996:Solutions; D014230:Triazoles